NB

Nepolian Bounapart Deivanayagam

Active Director Director DIN 09270289
DIN 09270289 First appointment Aug 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Nepolian Bounapart Deivanayagam

Data last updated:

Nepolian Bounapart Deivanayagam is a Director at Avanz Pharma Private Limited (since 2021). The company operates in Chemicals. Avanz Pharma Private Limited reported revenue of ₹21.3 Lakh (FY 2025).

DIN 09270289
Primary Designation Director
Industry Chemicals
First Appointment 05 Aug 2021
Oldest Company Age 5 yrs
Largest company Avanz Pharma Private Limited · ₹21.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avanz Pharma Private Limited U24233TN2021PTC145300
Director05 Aug 20212021₹21.3 Lakh (FY 2025)Active

Board colleagues of Nepolian Bounapart Deivanayagam

NameDINCompanyDesignation
Ramasamy Sivasubramanian09270288Avanz Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avanz Pharma Private Limited
Premium access

Shareholding and investment profile for Nepolian Bounapart Deivanayagam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nepolian Bounapart Deivanayagam

Nepolian Bounapart Deivanayagam currently holds 1 directorship: Avanz Pharma Private Limited (Director, since 05 Aug 2021, revenue ₹21.3 Lakh (FY 2025)).

Nepolian Bounapart Deivanayagam was first appointed on 05 Aug 2021 as Director at Avanz Pharma Private Limited.

The current boards of Nepolian Bounapart Deivanayagam's companies include Ramasamy Sivasubramanian (Avanz Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available